Zum Hauptinhalt springen
| Hans-Günter Meyer-Thompson | Hepatitiden

U.S. Food and Drug Administration Approves Gilead’s Vemlidy® (Tenofovir Alafenamide) for the Treatment of Chronic Hepatitis B Virus Infection